Company Filing History:
2 out of 245 
1 out of 832,891 Years Active: 2011-2013
Title: Antonella Torosantucci: Innovator in Antibody Research
Introduction
Antonella Torosantucci is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of antibody research, particularly in the development of protective anti-glucan antibodies. With a total of 3 patents, her work has the potential to impact the treatment of systemic fungal infections.
Latest Patents
One of her latest patents focuses on protective anti-glucan antibodies with a preference for β-1,3-glucans. These anti-β-1,3-glucan antibodies have been found to be protective against systemic fungal infections. The invention provides monoclonal antibodies that bind to β-1,3-glucan, along with hybridoma cell lines producing these antibodies. Additionally, it includes compositions comprising the antibodies and methods for using them in the treatment of microbial infections, particularly against infections related to β-1,3-glucan. Importantly, the antibodies developed are not specific for β-1,6-glucan.
Career Highlights
Throughout her career, Antonella has worked with notable organizations, including Novartis Vaccines & Diagnostics. Her research has been instrumental in advancing the understanding of antibody interactions and their applications in medical treatments.
Collaborations
Antonella has collaborated with esteemed colleagues, including Antonio Cassone. These partnerships have fostered innovation and contributed to the success of her research endeavors.
Conclusion
Antonella Torosantucci stands out as a leading inventor in the field of antibody research. Her innovative work on protective anti-glucan antibodies showcases her commitment to advancing medical science and improving treatment options for fungal infections.